IP Library Granted Patent US 9,662,376
Granted Patent B2
US 9,662,376 · App. 14/497,202 · Granted May 30, 2017

Formulations of recombinant furin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,662,376
App. No.
14/497,202
Granted
May 30, 2017
Kind
B2
Abstract

The present application provides stabilized formulations of furin (e.g., rfurin) containing a sugar, sugar alcohol, and/or non-ionic surfactant. As compared to non-stabilized compositions, the furin formulations disclosed herein retain greater amounts of furin activity and monomeric furin content, while reducing furin aggregation when stored and/or subjected to mechanical stress. Also provided are methods for stably diluting furin (e.g., rfurin) compositions.

Claims (36)

1. A stabilized aqueous composition of recombinant furin (rfurin), the composition comprising:

(a) from 8,000 U/mL to 500,000 U/mL rfurin;

(b) from 175 mM to 260 mM of a pharmaceutically acceptable salt;

(c) from 0.5 mM to 2 mM calcium;

(d) from 2% to 20% sugar or sugar alcohol;

(e) from 10 to 200 ppm non-ionic surfactant;

(f) from 10 to 200 mM buffering agent; and

(g) a pH from 5.5 to 7.5.

2. The composition of claim 1 , comprising from 180 mM to 260 mM of a pharmaceutically acceptable salt.

3. The composition of claim 1 , wherein the pharmaceutically acceptable salt is selected from the group consisting of sodium chloride and potassium chloride.

4. The composition of claim 1 , comprising 0.9±0.2 mM calcium.

5. The composition of claim 1 , comprising from 5% to 15% sugar or sugar alcohol.

6. The composition of claim 5 , comprising 10% sugar or sugar alcohol.

7. The composition of claim 1 , wherein the sugar or sugar alcohol is selected from the group consisting of sucrose, trehalose, mannitol, and a combination thereof.

8. The composition of claim 1 , wherein the non-ionic surfactant is polysorbate-80.

9. The composition of claim 1 , comprising from 10 ppm to 100 ppm non-ionic surfactant.

10. The composition of claim 9 , comprising 75 ppm non-ionic surfactant.

11. The composition of claim 1 , comprising from 50 mM to 150 mM buffering agent.

12. The composition of claim 1 , comprising 90±10 mM buffering agent.

13. The composition of claim 1 , wherein the buffering agent comprises acetate and HEPES.

14. The composition of claim 13 , comprising from 25 mM to 75 mM acetate and from 25 to 75 mM HEPES.

15. The composition of claim 13 , wherein the buffering agent comprises 45±5 mM acetate and 45±5 mM HEPES.

16. The composition of claim 1 , wherein the buffering agent comprises MES.

17. The composition of claim 1 , having a pH from 5.5 to 7.0.

18. The composition of claim 1 , having a pH from 5.5 to 6.5.

19. The composition of claim 1 , having a pH of 6.0.

20. The composition of claim 1 , having a pH of 6.0±0.2.

21. The composition of claim 1 , wherein the composition has increased stability when stored at 37° C. as compared to a rfurin composition that does not contain a sugar or sugar alcohol.

22. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin activity when stored at 37° C. as compared to a rfurin composition that does not contain a sugar or sugar alcohol.

23. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin monomer content when stored at 37° C. as compared to a rfurin composition that does not contain a sugar or sugar alcohol.

24. The composition of claim 1 , wherein the composition has increased stability when agitated as compared to a rfurin composition that does not contain a non-ionic surfactant.

25. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin activity when agitated as compared to a rfurin composition that does not contain a non-ionic surfactant.

26. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin monomer content when agitated as compared to a rfurin composition that does not contain a non-ionic surfactant.

27. The composition of claim 1 , wherein the composition has increased stability when diluted as compared to a rfurin composition that does not contain a non-ionic surfactant.

28. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin activity when diluted as compared to a rfurin composition that does not contain a non-ionic surfactant.

29. The composition of claim 1 , wherein the composition maintains a higher percentage of rfurin monomer content when diluted as compared to a rfurin composition that does not contain a non-ionic surfactant.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036368/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036369/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2014
From: HASSLACHER, MEINHARD; CITKOWICZ, ANDRZEJ; WHITE, CATHERINE; FRANKE, KEN
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 034314/0367 →